about
IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptorsThe human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portionsIdentification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating moleculeMolecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domainsIdentification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysisDNAM-1 and PVR regulate monocyte migration through endothelial junctionsThe natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimerNK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?The three-dimensional structure of the human NK cell receptor NKp44, a triggering partner in natural cytotoxicityStructure of the human NK cell triggering receptor NKp46 ectodomainSelective cross-talk among natural cytotoxicity receptors in human natural killer cellsHuman natural killer cell receptors: insights into their molecular function and structureRole of the calpain-calpastatin system in the density-dependent growth arrestThe immune inhibitory receptor LAIR-1 is highly expressed by plasmacytoid dendritic cells and acts complementary with NKp44 to control IFNα production.NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27Crystallization and preliminary crystallographic characterization of the extracellular Ig-like domain of human natural killer cell activating receptor NKp44.Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.Human natural killer cell activating receptors.Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activationModulation of CD112 by the alphaherpesvirus gD protein suppresses DNAM-1-dependent NK cell-mediated lysis of infected cells.CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells.Human NK cells and their receptors.B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape.'Emergency exit' of bone-marrow-resident CD34(+)DNAM-1(bright)CXCR4(+)-committed lymphoid precursors during chronic infection and inflammationInhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptorEffect of tumor cells and tumor microenvironment on NK-cell function.Involvement of exon 6-mediated calpastatin intracellular movements in the modulation of calpain activation.Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias.Role of NK cells in immunotherapy and virotherapy of solid tumors.Pseudorabies Virus US3 Protein Kinase Protects Infected Cells from NK Cell-Mediated Lysis via Increased Binding of the Inhibitory NK Cell Receptor CD300a.NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures.Direct involvement of CD56 in cytokine-induced killer-mediated lysis of CD56+ hematopoietic target cells.Molecular and functional characterization of NKG2D, NKp80, and NKG2C triggering NK cell receptors in rhesus and cynomolgus macaques: monitoring of NK cell function during simian HIV infection.Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules.Molecular structures of HLA-specific human NK cell receptors.Characterization of a cyclosporin A-sensitive activation pathway in cultured T and natural killer cells.The Innate Immune Cross Talk between NK Cells and Eosinophils Is Regulated by the Interaction of Natural Cytotoxicity Receptors with Eosinophil Surface LigandsNatural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment.The corticosteroid-induced inhibitory effect on NK cell function reflects down-regulation and/or dysfunction of triggering receptors involved in natural cytotoxicity.NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection.
P50
Q24300426-E3425E5F-BB76-4436-86D1-F532097218DDQ24310543-FC31EFCB-A3D0-46DD-9BA5-6F927461178AQ24314704-1BDA5847-E8E2-40C7-B1F9-E53A13B0320CQ24317666-ED3E9959-1F42-4849-91D7-6487AB55EB6EQ24562910-58DAB20C-ED73-4FE5-8D8E-703B9C3662C0Q24647699-0496094E-2E71-438F-BF9B-6CC9B16A076CQ24677386-9F44C5EE-1B26-4C07-936A-29FCED196C01Q26746478-0AF5B4E4-188B-4BB8-A7AA-5FDB8F4638E5Q27641400-D4F2C465-2B39-4987-95C3-153243655187Q27641939-74B8D963-3083-4630-AE82-86A07E5A922AQ28202599-0BF5131F-1024-4A7F-8FD0-58BC6E3E87F3Q28241698-F3247577-AEDA-43E1-95FE-358A5B846D66Q28579934-0C690B5C-D01E-47E9-906B-C7B207194FBCQ33769011-181C5AE6-4626-4552-8E35-E8FA0AAF22CFQ33798745-DD9CD27A-11D1-4402-8416-0A8202D79E43Q34152127-17DFF582-DDA3-4015-8544-809ACA066CA7Q34178128-A971384F-524B-4B01-8C56-B453CFAC2008Q34277965-0AC534EA-AEF9-4E62-8D9C-B233FA5580F3Q34490829-9160BC1D-660F-43CB-A040-67F01A1531CDQ34526520-6342C5B5-0661-473A-985C-3F31111F96D1Q34572976-0CA2F75B-0D3F-492F-9390-84B6056303FBQ35035740-6EC66892-4866-43EE-BD52-C1B1ACB9710EQ35798978-CCAEF122-B45E-427D-A331-DFEB1C167C65Q36145878-60BBBB68-12A2-439C-A98F-9D53B26802CEQ36364483-BC030276-8960-4CB0-81EE-B50FFF4B6A17Q38207947-3011910E-EA60-4B5D-9220-30869D725339Q38357937-C555E350-612B-4931-AF5A-2E5D4D792653Q38569646-24F481AC-E87E-4841-AD1A-A2D88C4F601EQ38575116-4D00E890-171A-457C-B488-12FF93B977BEQ38818598-389D70E9-63C4-493A-AF72-7FBB63367A08Q38833469-E02EEAE7-B9EB-45B7-99D1-B9AC04795FFAQ38958398-D210D934-5208-45FD-9EF9-6B4991D9D340Q40432579-A0B4ADF5-5856-40B5-9E16-729F86920282Q41065335-A08005B9-69CA-4494-A389-D929C0AD0CF0Q41242309-68E11A78-3C6E-4F16-9138-0389634102C1Q41475781-1C4EB2DA-4810-40CB-A17B-4F69A09959AEQ42146798-150719C5-9A35-4ABB-A6EC-CEFC46A6F50DQ43185293-FCD35691-1746-443B-88E9-E938D6D92171Q45059554-7F3D5FEC-DB3A-4453-945A-F77D56EC9DFFQ45133092-37199735-CFB4-4BB1-9DA7-189AB50F0FF7
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Claudia Cantoni
@ast
Claudia Cantoni
@en
Claudia Cantoni
@es
Claudia Cantoni
@nl
كلوديا كانتوني
@ar
type
label
Claudia Cantoni
@ast
Claudia Cantoni
@en
Claudia Cantoni
@es
Claudia Cantoni
@nl
كلوديا كانتوني
@ar
prefLabel
Claudia Cantoni
@ast
Claudia Cantoni
@en
Claudia Cantoni
@es
Claudia Cantoni
@nl
كلوديا كانتوني
@ar
P106
P1153
35885190900
P21
P31
P496
0000-0001-6471-1424